Submitted by Anonymous (not verified) on 24 October 2024 - 14:58
Pharmacovigilance Risk Assessment Committee (PRAC): 31 August - 3 September 2026, European Medicines Agency, Amsterdam, the Netherlands, from 31 August 2026 to 3 September 2026
Source: